One of the most important programs of our Texas Medical Center Digestive Diseases Center (called DDC) is the Pilot and Feasibility (P/F) Program. The goals of the P/F Program are to provide developmental funds to support (1) young investigators starting a career in gastrointestinal (GI) research, or (2) to foster the development of GI- related research by both junior faculty and established investigators in non-GI related fields in the Texas Medical Center. This is accomplished by supporting investigator-initiated scientific studies to develop preliminary data for new research projects. Novel approaches to studying GI-related areas complementing the scope of our Center are encouraged. Awards are made following a rigorous peer-review system that involves an initial evaluation for scientific merit by a Scientific Review Committee, including the DDC Internal Advisory Committee members and ad hoc scientists in the Texas Medical Center, and the External Advisors of our DDC. This core has a strong record of accomplishments. In the past 10 years, we have supported 68 P/F recipients, of whom 41 have gone on to receive $40,172,685 in external direct cost funding representing a 60% success rate and yielding a 23-fold return on investment (ROI) of DDC funds. We are requesting $100,000/year in years 16-20 to continue this PF program. This funding will be significantly enhanced each year by additional commitments from our three supporting Institutions, including $25,000 from The University of Texas Health Science Center (UTHSC), $25,000 from The University of Texas M.D. Anderson Cancer Center (MDACC) and $115,000 from Baylor College of Medicine (BCM). All investigators whose P/F Applications are approved for funding have priority access to our Cores for 1 year, or for the duration of their award. From 2013-2016, we received between 17-26 applications for each round of awards. To be funded in 2017, and for this competitive renewal application, we received 41 letters of intent and 22 completed applications for review. The top 4 proposals are included in this competitive renewal application to illustrate the breadth and quality of the new GI research our DDC is able to stimulate and facilitate. The PF program has a Director and two Assistant Directors, representing the three institutions (BCM, UTHSC, MDACC), and a Scientific Review Committee. We have several formal processes for soliciting and reviewing PF Proposals. Considerations for review, ranking and funding of PF proposals include project novelty, feasibility, qualifications and productivity of applicants, relationship to our DDC theme, the likelihood that the project will lead to new knowledge and the acquisition of external funding, and use of our DDC cores. Our P/F Program, pediatric and adult-GI training programs that include career-development initiatives open to all DDC members help recruit new faculty and foster collaborative, multidisciplinary interactions among junior and senior DDC investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK056338-16
Application #
9454078
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2018-05-01
Project End
2023-02-28
Budget Start
2018-05-01
Budget End
2019-02-28
Support Year
16
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Donaldson, G P; Ladinsky, M S; Yu, K B et al. (2018) Gut microbiota utilize immunoglobulin A for mucosal colonization. Science 360:795-800
White, Donna L; Hoogeveen, Ron C; Chen, Liang et al. (2018) A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med 7:2180-2191
Wang, Changjun; Zaheer, Mahira; Bian, Fang et al. (2018) Sjögren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice. Int J Mol Sci 19:
Blutt, Sarah E; Crawford, Sue E; Ramani, Sasirekha et al. (2018) Engineered Human Gastrointestinal Cultures to Study the Microbiome and Infectious Diseases. Cell Mol Gastroenterol Hepatol 5:241-251
Yu, Wangie; Chen, Yunyun; Dubrulle, Julien et al. (2018) Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep 8:4306
Mindikoglu, Ayse L; Pappas, Stephen C (2018) Predictors of Response to Terlipressin in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 16:1174
Zhou, Yong; Hancock, John F (2018) Electron microscopy combined with spatial analysis: quantitative mapping of the nano-assemblies of plasma membrane-associating proteins and lipids. Biophys Rep 4:320-328
Rajan, Anubama; Vela, Lucy; Zeng, Xi-Lei et al. (2018) Novel Segment- and Host-Specific Patterns of Enteroaggregative Escherichia coli Adherence to Human Intestinal Enteroids. MBio 9:
VanWagner, Lisa B; Kanwal, Fasiha (2018) Hepatology in a changing health care landscape: A call for health services research. Hepatology 68:1154-1162
Zou, Winnie Y; El-Serag, Hashem B; Sada, Yvonne H et al. (2018) Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci 63:1173-1181

Showing the most recent 10 out of 1121 publications